Header cover image

Norwegian (OSEAX) Pharma Industry Analysis

UpdatedMay 09, 2026
DataAggregated Company Financials
Companies5
  • 7D-2.3%
  • 3M3.1%
  • 1Y3.1%
  • YTD-4.6%

Over the last 7 days, the Pharma industry has dropped 1.7%, driven by pullbacks from every company within the industry. In the past year, the industry has gained 4.8%. Looking forward, earnings are forecast to grow by 60% annually.

Industry Valuation and Performance

Has the Norwegian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 09 May 2026NOK 3.6bNOK 1.7b-NOK 23,226,000.0016.7x-156x2.1x
Mon, 06 Apr 2026NOK 3.5bNOK 1.6b-NOK 67,842,000.0013x-51.9x2.2x
Wed, 04 Mar 2026NOK 3.7bNOK 1.6b-NOK 60,027,434.0012.9x-62x2.3x
Fri, 30 Jan 2026NOK 3.6bNOK 1.6b-NOK 67,438,434.00438.6x-53.5x2.3x
Sun, 28 Dec 2025NOK 3.6bNOK 1.6b-NOK 67,438,434.00436.7x-54x2.3x
Tue, 25 Nov 2025NOK 3.2bNOK 1.6b-NOK 79,791,434.00383.8x-40.3x2.1x
Thu, 23 Oct 2025NOK 3.2bNOK 1.5b-NOK 83,687,434.0012.6x-38.5x2.1x
Sat, 20 Sep 2025NOK 3.4bNOK 1.5b-NOK 83,687,434.0013.8x-40.1x2.2x
Mon, 18 Aug 2025NOK 3.6bNOK 1.5b-NOK 127,182,434.0014.2x-28.1x2.4x
Wed, 16 Jul 2025NOK 3.5bNOK 1.5b-NOK 91,864,434.00381.6x-37.6x2.2x
Fri, 13 Jun 2025NOK 3.2bNOK 1.5b-NOK 115,163,434.00331.2x-28x2.1x
Sun, 11 May 2025NOK 3.3bNOK 1.5b-NOK 122,678,000.00318.2x-26.9x2.2x
Tue, 08 Apr 2025NOK 3.0bNOK 1.5b-NOK 131,427,000.00132.7x-22.4x2x
Thu, 06 Mar 2025NOK 3.0bNOK 1.5b-NOK 13,494,743.00152.1x-221.8x2x
Sat, 01 Feb 2025NOK 3.3bNOK 1.5bNOK 22.4m22x148.8x2.3x
Mon, 30 Dec 2024NOK 3.3bNOK 1.5bNOK 22.4m23.3x146.4x2.2x
Wed, 27 Nov 2024NOK 2.8bNOK 1.5bNOK 34.6m22.5x82.1x1.9x
Fri, 25 Oct 2024NOK 3.2bNOK 1.5bNOK 45.2m22.3x70.4x2.1x
Sun, 22 Sep 2024NOK 3.2bNOK 1.5bNOK 45.2m21.9x71.7x2.2x
Tue, 20 Aug 2024NOK 2.8bNOK 1.5bNOK 93.8m22.1x30.3x1.9x
Thu, 18 Jul 2024NOK 3.0bNOK 1.5bNOK 49.7m158.8x59.9x2x
Sat, 15 Jun 2024NOK 3.4bNOK 1.5bNOK 7.6m190.4x452.7x2.3x
Mon, 13 May 2024NOK 3.2bNOK 1.5bNOK 3.0m2943.2x1075x2.2x
Wed, 10 Apr 2024NOK 3.2bNOK 1.5bNOK 7.6m157.2x420.3x2.2x
Fri, 08 Mar 2024NOK 3.1bNOK 1.5bNOK 33.1m172x94.1x2.1x
Sun, 04 Feb 2024NOK 3.5bNOK 1.4bNOK 18.6m25.4x187.3x2.5x
Tue, 02 Jan 2024NOK 3.5bNOK 1.4bNOK 18.6m24.7x190.1x2.5x
Thu, 30 Nov 2023NOK 3.0bNOK 1.4bNOK 18.6m24.3x162.9x2.1x
Sat, 28 Oct 2023NOK 3.3bNOK 1.4b-NOK 8,236,125.0027.7x-403x2.4x
Mon, 25 Sep 2023NOK 3.4bNOK 1.3b-NOK 53,836,125.0052.9x-62.9x2.5x
Wed, 23 Aug 2023NOK 2.8bNOK 1.3b-NOK 60,691,125.0082.5x-45.7x2.1x
Fri, 21 Jul 2023NOK 3.0bNOK 1.2b-NOK 60,357,125.0074.5x-50x2.4x
Sun, 18 Jun 2023NOK 3.1bNOK 1.2b-NOK 104,503,000.0078x-30.1x2.5x
Tue, 16 May 2023NOK 3.2bNOK 1.2b-NOK 104,474,000.0074.8x-30.2x2.5x
Price to Earnings Ratio

-30.2x


Total Market Cap: NOK 3.2bTotal Earnings: -NOK 104,474,000.00Total Revenue: NOK 1.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Pharma Industry Price to Earnings3Y Average 37.6x202420252026
Current Industry PE
  • Investors are relatively neutral on the Norwegian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 2.2x.
Past Earnings Growth
  • Losses for companies in the Pharmaceuticals industry have mostly stayed the same over the last three years.
  • Meanwhile revenues for these companies have grown 8.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, losses haven't seen much improvement.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market-2.98%
Healthcare-0.49%
Pharma-2.33%
Pharma-2.33%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News